标题: | 中华医学会肺癌临床诊疗指南(2024版) |
title: | Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition) |
版本: | 更新版 |
version: | Updated |
分类: | 标准指南 |
classification: | Standard guideline |
领域: | 综合 |
field: | Comprehensive guideline |
国家和地区: | 中国 |
Country and region: | China |
指南使用者: | 各级临床医务人员。 |
Guide users: | Clinical medical personnel at all levels |
证据分级方法: | GRADE分级 |
Evidence grading method: | GRADE classification |
制定单位: | 中华医学会 |
Formulating unit: | Chinese Medical Association |
注册时间: | 2024-07-22 |
Registration time: | |
注册编号: | PREPARE-2024CN032 |
Registration number: | |
指南制订的目的: | 为进一步规范中国肺癌的防治措施、提高肺癌的诊疗水平、改善患者的预后、为各级临床医务人员提供专业的循证医学建议,中华医学会组织呼吸内科、肿瘤内科、胸外科、放疗科、影像科和病理科专家,经过共识会议制定了中华医学会肺癌临床诊疗指南(2024版)。 |
Purpose of the guideline: | To further standardize lung cancer prevention and treatment measures in China, enhance the quality of diagnosis and treatment, improve patient prognosis, and provide evidence-based medical guidance for clinicians at all levels, the Chinese Medical Association convened experts from respiratory medicine, oncology, thoracic surgery, radiotherapy, imaging, and pathology to develop the Chinese Medical Association's Clinical Diagnosis and Treatment Guidelines for Lung Cancer (2024 edition). |
最新注册